| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |